Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Braz. j. med. biol. res ; 40(10): 1339-1343, Oct. 2007. graf
Article in English | LILACS | ID: lil-461358

ABSTRACT

In the present study, we investigated the in vitro anti-tumoral activities of fractions from aqueous extracts of the husk fiber of the typical A and common varieties of Cocos nucifera (Palmae). Cytotoxicity against leukemia cells was determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Cells (2 x 104/well) were incubated with 0, 5, 50 or 500 æg/mL high- or low-molecular weight fractions for 48 h, treated with MTT and absorbance was measured with an ELISA reader. The results showed that both varieties have almost similar antitumoral activity against the leukemia cell line K562 (60.1 ± 8.5 and 47.5 ± 11.9 percent for the typical A and common varieties, respectively). Separation of the crude extracts with Amicon membranes yielded fractions with molecular weights ranging in size from 1-3 kDa (fraction A) to 3-10 kDa (fraction B) and to more than 10 kDa (fraction C). Cells were treated with 500 æg/mL of these fractions and cytotoxicity was evaluated by MTT. Fractions ranging in molecular weight from 1-10 kDa had higher cytotoxicity. Interestingly, C. nucifera extracts were also active against Lucena 1, a multidrug-resistant leukemia cell line. Their cytotoxicity against this cell line was about 50 percent (51.9 ± 3.2 and 56.3 ± 2.9 for varieties typical A and common, respectively). Since the common C. nucifera variety is extensively cultured in Brazil and the husk fiber is its industrial by-product, the results obtained in the present study suggest that it might be a very inexpensive source of new antineoplastic and anti-multidrug resistant drugs that warrants further investigation.


Subject(s)
Humans , Antineoplastic Agents, Phytogenic/pharmacology , Cocos/chemistry , Plant Extracts/pharmacology , Drug Screening Assays, Antitumor , Drug Resistance, Neoplasm/drug effects , /drug effects
2.
Rev. bras. farmacogn ; 14(supl): 11-14, 2004. graf, tab
Article in Portuguese | LILACS | ID: lil-570858

ABSTRACT

O presente trabalho avaliou as atividades antinociceptiva e antiinflamatória do óleo essencial de cascas de Duguetia lanceolata. Para isto, foram realizados os testes de contorções abdominais induzidas por ácido acético; tempo da lambida da pata induzida por formalina; e edema de pata induzido por carragenina. O número de contorções abdominais (DE50 = 21,79 mg/kg) e o tempo da lambida da pata 1ª fase (DE50 = 5,27 mg/kg) e 2ª fase (DE50 = 1,43 mg/ kg) foram reduzidos significativamente de forma dependente da dose. O material vegetal nas doses de 50, 100 e 200 mg/kg diminuíram de maneira expressiva o edema de pata em 20,83; 36,46 e 48,96 por cento, respectivamente. O óleo essencial de cascas de D. lanceolata possui efeitos antinociceptivo e antiinflamatório por prováveis ações central e periférica.


The present work evaluated the antinociceptive and anti-inflammatory activities of the essential oil from barks of Duguetia lanceolata. For this purpose, acetic acid writhing, formalin and carrageenan tests were performed. The number of writhings (ED50 = 21,79 mg/kg) and the lick of the paw 1st phase (ED50 = 5,27 mg/kg) e 2nd phase (ED50 = 1,43 mg/kg) reduced significantly in a dosedependent form. The doses 50, 100 and 200 mg/kg reduced the paw edema significantly in 20,83; 36,46 and 48,96 percent, respectively. These results suggest that the essential oil from barks of D. lanceolata has antinociceptive and anti-inflammatory effects and probably the mechanisms(s) involve central and peripheric actions.

SELECTION OF CITATIONS
SEARCH DETAIL